SCHEMBL21570658

SCHEMBL21570658

COc1ccccc1C(OC1C[C@@H]2CC3(C[C@@H]2C1)OCC(C)(C)CO3)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ACACA Q13085 9/20 0.36
▸ EPHX2 P34913 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ACACB O00763 7/20 0.35
▸ HCRTR1 O43613 1/20 0.33
▸ HCRTR2 O43614 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ FAAH O00519 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ OPRM1 P35372 1/20 0.32
▸ OPRD1 P41143 1/20 0.32
▸ OPRK1 P41145 1/20 0.32
▸ OPRL1 P41146 1/20 0.32
▸ ITGB1 P05556 3/20 0.32
▸ ITGA4 P13612 3/20 0.32
▸ ITGB7 P26010 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21570663 0.85 HTT (0.35) ACACAEPHX2POLBHTTNPSR1
SCHEMBL21570630 0.84 ACACA (0.37) ACACAPOLBHTTNPSR1L3MBTL1
SCHEMBL21570639 0.82 ACACA (0.43) ACACAEPHX2POLBHTTNPSR1
SCHEMBL29581152 0.81 ACACA (0.42) ACACAPOLBHTTNPSR1L3MBTL1
SCHEMBL22870047 0.81 ACACA (0.42) ACACAPOLBHTTNPSR1L3MBTL1
SCHEMBL22869915 0.81 ACACA (0.42) ACACAPOLBHTTNPSR1L3MBTL1
SCHEMBL28683936 0.81 ACACA (0.42) ACACAPOLBHTTNPSR1L3MBTL1
SCHEMBL21570681 0.77 ACACA (0.43) ACACAPOLBHTTNPSR1L3MBTL1
SCHEMBL21570700 0.76 EPHX2 (0.38) ACACAEPHX2POLBHTTNPSR1
SCHEMBL21570598 0.75 ACACA (0.45) ACACAPOLBHTTNPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3571205-B1 THIENOPYRIMIDINE DERIVATIVE AND USE THEREOF IN MEDICINE SUNSHINE LAKE PHARMA CO LTD (CN) 2023-08-30 — — EP disclosed
US-10759812-B2 Thienopyrimidine derivative and use thereof in medicine SUNSHINE LAKE PHARMA CO., LTD. (CN) 2020-09-01 — — US disclosed
US-20190352311-A1 THIENOPYRIMIDINE DERIVATIVE AND USE THEREOF IN MEDICINE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2019-11-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190352311-A1 THIENOPYRIMIDINE DERIVATIVE AND USE THEREOF IN MEDICINE ACACA, ACACB, PC ACACA 1/4885EPHX2 621/4885POLB 1001/4885
US-10759812-B2 Thienopyrimidine derivative and use thereof in medicine ACACA, ACACB, PC ACACA 1/4885EPHX2 621/4885POLB 1001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback